A real-world study on characteristics, treatments and outcomes in US patients with advanced stage ovarian cancer.

Daniel C BeachlerFrancois-Xavier LamyLeo RussoDevon H TaylorJade DinhRuihua YinAziza Jamal-AllialSamuel DychterStephan LanesPatrice Verpillat

Published in: Journal of ovarian research (2020)

This study describes commercially insured US patients with advanced stage ovarian cancer from 2010 to 2018, and observed diverse treatment patterns, incidence of numerous HOIs, and limited survival in this population.

Keyphrases

risk factors
metabolic syndrome
insulin resistance
combination therapy